false000138584912/312024Q3Common shares, no par valuexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiso4217:AUDxbrli:pureefr:purchaseAgreementefr:mineral_concessionutr:acreutr:miefr:subsidiaryefr:percentagepointiso4217:CADxbrli:sharesiso4217:CADiso4217:AUDxbrli:shares00013858492024-01-012024-09-300001385849exch:XNYS2024-01-012024-09-3000013858492024-10-280001385849exch:XTSE2024-01-012024-09-3000013858492024-07-012024-09-3000013858492023-07-012023-09-3000013858492023-01-012023-09-3000013858492024-09-3000013858492023-12-3100013858492023-09-300001385849us-gaap:CommonStockMember2023-12-310001385849us-gaap:RetainedEarningsMember2023-12-310001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001385849us-gaap:ParentMember2023-12-310001385849us-gaap:NoncontrollingInterestMember2023-12-310001385849us-gaap:RetainedEarningsMember2024-01-012024-03-310001385849us-gaap:ParentMember2024-01-012024-03-310001385849us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100013858492024-01-012024-03-310001385849us-gaap:CommonStockMember2024-01-012024-03-310001385849us-gaap:CommonStockMemberus-gaap:StockAppreciationRightsSARSMember2024-01-012024-03-310001385849us-gaap:CommonStockMember2024-03-310001385849us-gaap:RetainedEarningsMember2024-03-310001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001385849us-gaap:ParentMember2024-03-310001385849us-gaap:NoncontrollingInterestMember2024-03-3100013858492024-03-310001385849us-gaap:RetainedEarningsMember2024-04-012024-06-300001385849us-gaap:ParentMember2024-04-012024-06-300001385849us-gaap:NoncontrollingInterestMember2024-04-012024-06-3000013858492024-04-012024-06-300001385849us-gaap:CommonStockMember2024-04-012024-06-300001385849us-gaap:CommonStockMember2024-06-300001385849us-gaap:RetainedEarningsMember2024-06-300001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001385849us-gaap:ParentMember2024-06-300001385849us-gaap:NoncontrollingInterestMember2024-06-3000013858492024-06-300001385849us-gaap:RetainedEarningsMember2024-07-012024-09-300001385849us-gaap:ParentMember2024-07-012024-09-300001385849us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001385849us-gaap:CommonStockMember2024-07-012024-09-300001385849us-gaap:CommonStockMember2024-09-300001385849us-gaap:RetainedEarningsMember2024-09-300001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001385849us-gaap:ParentMember2024-09-300001385849us-gaap:NoncontrollingInterestMember2024-09-300001385849us-gaap:CommonStockMember2022-12-310001385849us-gaap:RetainedEarningsMember2022-12-310001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001385849us-gaap:ParentMember2022-12-310001385849us-gaap:NoncontrollingInterestMember2022-12-3100013858492022-12-310001385849us-gaap:RetainedEarningsMember2023-01-012023-03-310001385849us-gaap:ParentMember2023-01-012023-03-310001385849us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100013858492023-01-012023-03-310001385849us-gaap:CommonStockMember2023-01-012023-03-310001385849us-gaap:CommonStockMember2023-03-310001385849us-gaap:RetainedEarningsMember2023-03-310001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001385849us-gaap:ParentMember2023-03-310001385849us-gaap:NoncontrollingInterestMember2023-03-3100013858492023-03-310001385849us-gaap:RetainedEarningsMember2023-04-012023-06-300001385849us-gaap:ParentMember2023-04-012023-06-300001385849us-gaap:NoncontrollingInterestMember2023-04-012023-06-3000013858492023-04-012023-06-300001385849us-gaap:CommonStockMember2023-04-012023-06-300001385849us-gaap:CommonStockMember2023-06-300001385849us-gaap:RetainedEarningsMember2023-06-300001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001385849us-gaap:ParentMember2023-06-300001385849us-gaap:NoncontrollingInterestMember2023-06-3000013858492023-06-300001385849us-gaap:RetainedEarningsMember2023-07-012023-09-300001385849us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001385849us-gaap:CommonStockMember2023-07-012023-09-300001385849us-gaap:ParentMember2023-07-012023-09-300001385849us-gaap:CommonStockMember2023-09-300001385849us-gaap:RetainedEarningsMember2023-09-300001385849us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001385849us-gaap:ParentMember2023-09-300001385849us-gaap:NoncontrollingInterestMember2023-09-300001385849us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001385849us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001385849us-gaap:StockAppreciationRightsSARSMember2024-01-012024-09-300001385849us-gaap:StockAppreciationRightsSARSMember2023-01-012023-09-300001385849us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-06-030001385849srt:ScenarioForecastMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-06-042025-06-030001385849srt:ScenarioForecastMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-06-042024-12-310001385849srt:MaximumMemberus-gaap:PrivatePlacementMembersrt:ScenarioForecastMember2024-08-032024-12-310001385849us-gaap:PrivatePlacementMember2024-09-242024-09-240001385849efr:DonaldProectJVMember2024-09-250001385849efr:DonaldProectJVMemberefr:AstronCorporationLimitedMember2024-09-250001385849efr:RadTranLLCAssetAcquisitionMember2024-08-162024-08-160001385849efr:RadTranLLCAssetAcquisitionMember2024-08-160001385849efr:RadTranLLCAssetAcquisitionMembersrt:MaximumMember2024-08-162024-08-160001385849efr:RadTranLLCAssetAcquisitionMemberefr:MilestoneAchievementOneMember2024-08-162024-08-160001385849efr:RadTranLLCAssetAcquisitionMemberefr:MilestoneAchievementTwoMember2024-08-162024-08-160001385849efr:RadTranLLCAssetAcquisitionMemberefr:MilestoneAchievementThreeMember2024-08-162024-08-160001385849efr:RadTranLLCAssetAcquisitionMember2024-08-172024-09-300001385849efr:RadTranLLCAssetAcquisitionMember2024-09-300001385849efr:MarketableDebtSecuritiesMember2024-09-300001385849us-gaap:LandMember2024-09-300001385849us-gaap:LandMember2023-12-310001385849srt:MinimumMemberefr:PlantFacilitiesMember2024-09-300001385849srt:MaximumMemberefr:PlantFacilitiesMember2024-09-300001385849efr:PlantFacilitiesMember2024-09-300001385849efr:PlantFacilitiesMember2023-12-310001385849srt:MinimumMemberefr:MiningEquipmentMember2024-09-300001385849srt:MaximumMemberefr:MiningEquipmentMember2024-09-300001385849efr:MiningEquipmentMember2024-09-300001385849efr:MiningEquipmentMember2023-12-310001385849us-gaap:VehiclesMember2024-09-300001385849us-gaap:VehiclesMember2023-12-310001385849srt:MinimumMemberefr:OfficeFurnitureAndEquipmentMember2024-09-300001385849srt:MaximumMemberefr:OfficeFurnitureAndEquipmentMember2024-09-300001385849efr:OfficeFurnitureAndEquipmentMember2024-09-300001385849efr:OfficeFurnitureAndEquipmentMember2023-12-310001385849us-gaap:ConstructionInProgressMember2024-09-300001385849us-gaap:ConstructionInProgressMember2023-12-310001385849efr:WhiteMesaMillMember2024-07-012024-09-300001385849efr:WhiteMesaMillMember2023-07-012023-09-300001385849efr:WhiteMesaMillMember2024-01-012024-09-300001385849efr:WhiteMesaMillMember2023-01-012023-09-300001385849efr:MineralPropertiesDomain2023-07-012023-09-300001385849efr:MineralPropertiesDomain2024-07-012024-09-300001385849efr:MineralPropertiesDomain2024-01-012024-09-300001385849efr:MineralPropertiesDomain2023-01-012023-09-300001385849efr:SheepMountainMember2024-09-300001385849efr:SheepMountainMember2023-12-310001385849efr:BahiaProjectMember2024-09-300001385849efr:BahiaProjectMember2023-12-310001385849efr:UranerzISRPropertiesMember2024-09-300001385849efr:UranerzISRPropertiesMember2023-12-310001385849efr:RocaHondaMember2024-09-300001385849efr:RocaHondaMember2023-12-310001385849efr:PinyonPlainMember2024-09-300001385849efr:PinyonPlainMember2023-12-310001385849efr:OtherMember2024-09-300001385849efr:OtherMember2023-12-3100013858492023-02-102023-02-1000013858492023-02-100001385849efr:AltaMesaDivestitureMember2023-02-142023-02-140001385849efr:AltaMesaDivestitureMember2023-02-140001385849efr:AltaMesaDivestitureMember2023-05-032023-05-030001385849efr:AltaMesaDivestitureMember2023-05-030001385849efr:AtTheMarketSaleOfStockMember2024-01-012024-09-300001385849efr:AtTheMarketSaleOfStockMember2024-07-012024-09-300001385849efr:AtTheMarketSaleOfStockMember2023-01-012023-09-300001385849efr:AtTheMarketSaleOfStockMember2023-07-012023-09-300001385849us-gaap:StockAppreciationRightsSARSMember2024-07-012024-09-300001385849us-gaap:StockAppreciationRightsSARSMember2023-07-012023-09-300001385849srt:MaximumMemberefr:StockIncentivePlanMemberefr:TotalShareAuthorizationMember2024-06-110001385849srt:MaximumMemberefr:StockIncentivePlanMemberefr:FullValueShareAuthorizationMember2024-06-110001385849efr:StockIncentivePlanMemberefr:TotalShareAuthorizationMember2024-09-300001385849efr:StockIncentivePlanMemberefr:FullValueShareAuthorizationMember2024-09-300001385849us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001385849us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001385849us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001385849us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001385849us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001385849us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001385849us-gaap:StockOptionMemberus-gaap:RestrictedStockUnitsRSUMember2023-12-310001385849us-gaap:StockOptionMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001385849us-gaap:StockOptionMemberus-gaap:RestrictedStockUnitsRSUMember2024-09-300001385849us-gaap:StockAppreciationRightsSARSMember2023-12-310001385849us-gaap:StockAppreciationRightsSARSMember2024-09-300001385849us-gaap:StockOptionMemberus-gaap:StockAppreciationRightsSARSMember2023-12-310001385849us-gaap:StockOptionMemberus-gaap:StockAppreciationRightsSARSMember2024-01-012024-09-300001385849us-gaap:StockOptionMemberus-gaap:StockAppreciationRightsSARSMember2024-09-300001385849srt:MaximumMember2024-01-012024-09-300001385849efr:PerformanceBasedOptionsMember2024-01-3100013858492024-01-240001385849us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:EmployeeStockOptionMember2024-01-252024-01-250001385849us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:EmployeeStockOptionMember2024-01-252024-01-250001385849srt:MinimumMember2023-12-310001385849srt:MaximumMember2023-12-310001385849srt:MinimumMember2024-01-012024-09-300001385849srt:MinimumMember2024-09-300001385849srt:MaximumMember2024-09-300001385849us-gaap:StockOptionMember2023-12-310001385849us-gaap:StockOptionMember2024-01-012024-09-300001385849us-gaap:StockOptionMember2024-09-300001385849us-gaap:MiningPropertiesAndMineralRightsMember2024-09-300001385849efr:CanyonProjectMember2024-09-300001385849efr:CanyonProjectMember2023-12-310001385849us-gaap:MeasurementInputPriceVolatilityMember2023-02-142023-02-140001385849efr:MeasurementInputYieldMember2023-02-142023-02-1400013858492023-11-092023-11-0900013858492023-11-0900013858492023-11-292023-11-290001385849us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-09-300001385849us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-09-300001385849us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-09-300001385849us-gaap:FairValueMeasurementsRecurringMember2024-09-300001385849us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2024-09-300001385849us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2024-09-300001385849us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2024-09-300001385849us-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2024-09-300001385849us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2024-09-300001385849us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2024-09-300001385849us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2024-09-300001385849us-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2024-09-300001385849us-gaap:FairValueInputsLevel1Member2024-09-300001385849us-gaap:FairValueInputsLevel2Member2024-09-300001385849us-gaap:FairValueInputsLevel3Member2024-09-300001385849us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001385849us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001385849us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001385849us-gaap:FairValueMeasurementsRecurringMember2023-12-310001385849us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2023-12-310001385849us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2023-12-310001385849us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2023-12-310001385849us-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2023-12-310001385849us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableEquitySecuritiesMember2023-12-310001385849us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2023-12-310001385849us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2023-12-310001385849us-gaap:FairValueMeasurementsRecurringMemberefr:MarketableDebtSecuritiesMember2023-12-310001385849us-gaap:FairValueInputsLevel1Member2023-12-310001385849us-gaap:FairValueInputsLevel2Member2023-12-310001385849us-gaap:FairValueInputsLevel3Member2023-12-3100013858492024-08-1600013858492024-08-172024-09-300001385849efr:VirginiaEnergyResourcesIncMemberefr:CURMember2023-01-240001385849efr:VirginiaEnergyResourcesIncMemberefr:CURMember2023-01-242023-01-240001385849efr:VirginiaEnergyResourcesIncMemberefr:EnergyFuelsMember2023-01-240001385849efr:CURMemberefr:EnergyFuelsMember2023-01-240001385849efr:CURMember2023-12-052023-12-050001385849efr:IsoEnergyMember2023-12-050001385849us-gaap:PrivatePlacementMember2023-10-192023-10-190001385849us-gaap:PrivatePlacementMember2023-10-190001385849us-gaap:PrivatePlacementMember2023-12-052023-12-050001385849srt:DirectorMemberefr:ArkoseMiningVentureMemberefr:UnitedNuclearMember2024-09-300001385849srt:DirectorMemberefr:ArkoseMiningVentureMemberefr:EnergyFuelsMember2024-09-300001385849efr:ConsolidatedUraniumIncMember2024-07-012024-09-300001385849efr:ConsolidatedUraniumIncMember2023-07-012023-09-300001385849efr:ConsolidatedUraniumIncMember2024-01-012024-09-300001385849efr:ConsolidatedUraniumIncMember2023-01-012023-09-300001385849efr:ConsolidatedUraniumIncMember2024-09-300001385849efr:ConsolidatedUraniumIncMember2023-09-300001385849efr:ConsolidatedUraniumIncMember2023-12-310001385849us-gaap:SubsequentEventMemberefr:BaseResourcesLimitedMember2024-10-022024-10-020001385849efr:ToliaraProjectAssetAcquisitionMemberefr:BaseResourcesLimitedMember2018-01-012018-01-310001385849efr:ToliaraProjectAssetAcquisitionMemberefr:BaseResourcesLimitedMember2018-01-310001385849efr:ToliaraProjectAssetAcquisitionMemberefr:BaseResourcesLimitedMember2020-01-012020-01-310001385849efr:ToliaraProjectAssetAcquisitionMemberus-gaap:SubsequentEventMemberefr:BaseResourcesLimitedMember2024-10-162024-10-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________________ to ___________________

Commission file number: 001-36204
EF Logo_12.31.2022 10K.jpg
ENERGY FUELS INC.
(Exact name of registrant as specified in its charter)
Ontario,Canada98-1067994
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
225 Union Blvd., Suite 600
Lakewood,Colorado80228
(Address of principal executive offices)(Zip Code)

(303) 974-2140
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Shares, no par valueUUUUNYSE American
EFRToronto Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes      No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes      No



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes      No

As of October 28, 2024, the registrant had 196,602,660 common shares, without par value, outstanding.



ENERGY FUELS INC.
FORM 10-Q
For the Quarter Ended September 30, 2024
INDEX
 Page
PART I – FINANCIAL INFORMATION 
PART II – OTHER INFORMATION 
SIGNATURES 

3


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and the exhibits attached hereto (the “Quarterly Report”) contain “forward-looking statements” and “forward-looking information” within the meaning of applicable United States (“U.S.”) and Canadian securities laws (collectively, “forward-looking statements”), which may include, but are not limited to, statements with respect to Energy Fuels Inc.’s (the “Company’s” or “Energy Fuels’”): anticipated results and progress of our operations in future periods; planned exploration; development of our properties; plans related to our business, such as the ramp-up of our uranium business in response to improved uranium prices and the expansion of our rare earth elements (“REE”) initiatives, including work on our South Bahia heavy mineral sands (“HMS”) project in Brazil (the “Bahia Project”), our planned continued development of capabilities for the commercial separation of REEs at our White Mesa Mill (the “White Mesa Mill” or the “Mill”) in Utah, and our plans related to our recently acquired HMS properties, including the Kwale HMS project in Kenya (the “Kwale Project”) and the Toliara HMS and REE project in Madagascar (the “Toliara Project”) through the Company’s acquisition of Base Resources Limited (“Base” or “Base Resources”), which closed on October 2, 2024 (see Part I, Item 1, Note 17 – Subsequent Events), and the potential earn-in of up to a 49% joint venture interest in the Donald HMS and REE project in Australia (the “Donald Project”) pursuant to definitive agreements entered into between the parties, as previously announced on June 3, 2024, with the Company’s current earn-in interest at 3.21%; plans related to our potential recovery of radioisotopes at the Mill for use in the production of targeted alpha therapy (“TAT”) medical treatments; any plans related to the acquisition of additional uranium or uranium/vanadium mineral properties; any plans relating to the ramp-up of production or ongoing operations at any of our uranium, uranium/vanadium and/or HMS properties; historic estimates of resources and reserves; production estimates; maintenance and renewal of permits; expectations that the Company will be successful in agreeing to acceptable fiscal terms with the Government of Madagascar or in achieving and maintaining sufficient fiscal and legal stability or that the current suspension relating to the Toliara Project will be lifted in the near future or at all; and expectations for the outcome of pending litigation. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, schedules, assumptions, future events, or performance (often, but not always, using words or phrases such as “expects” or “does not expect,” “is expected,” “is likely,” “budgets,” “scheduled,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” “continues,” “plans,” “estimates,” or “believes,” and similar expressions or variations of such words and phrases or statements stating that certain actions, events or results “may,” “could,” “would,” “might,” or “will” be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.
Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. We believe that the expectations reflected in these forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct, and such forward-looking statements included in, or incorporated by reference into, this Quarterly Report should not be unduly relied upon.
Readers are cautioned that it would be unreasonable to rely on any such forward-looking statements as creating any legal rights, and that the forward-looking statements are not guarantees and may involve known and unknown risks and uncertainties, and that actual results are likely to differ (and may differ materially), and objectives and strategies may differ or change, from those expressed or implied in the forward-looking statements as a result of various factors. Such risks and uncertainties include, but are not limited to: global economic risks, such as the occurrence of a pandemic, political unrest or wars; cybersecurity risks associated with critical and other highly sensitive minerals of international interest, which are key to national security; litigation risks; risks associated with the restart and subsequent operation of any of our uranium, uranium/vanadium and HMS mines; risks associated with our commercial production of an REE carbonate (“RE Carbonate”) or separated REE oxides and the planned expansion of such production, and risks associated with the exploration and development of our Bahia Project in Brazil; risks associated with the potential recovery of radioisotopes for use in the Company’s TAT initiatives; risks associated with successfully closing and integrating potential business and mineral acquisitions into Company operations; risks associated with our joint ventures; international risks, including geopolitical and country risks, risks associated with negotiating and maintaining satisfactory fiscal and stability arrangements and obtaining foreign country government approvals on a timely basis or at all, and expropriation risks; risks associated with the failure of the Government of Madagascar to agree on fiscal terms or provide the approvals necessary to achieve sufficient fiscal and legal stability on acceptable terms and conditions or at all or the failure of the current suspension affecting the Toliara Project to be lifted on a timely basis or at all; risks associated with increased regulatory requirements applicable to our operations in response to pressure from special interest groups or otherwise; and risks generally encountered in the exploration, development, operation, closure and reclamation of mineral properties and processing and recovery facilities. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation the following risks:
4


global economic risks, including the occurrence of unforeseen or catastrophic events, such as political unrest, wars or the emergence of a widespread health emergency, which could create operational, economic and financial disruptions for an indeterminate period of time that could materially impact our business, operations, personnel and financial condition;
risks associated with Mineral Reserve and Mineral Resource estimates, including the risk of errors in assumptions or methodologies and changes to estimate disclosure rules and regulations;
risks associated with estimating mineral extraction and recovery, forecasting future price levels necessary to support mineral extraction and recovery, and our ability to increase mineral extraction and recovery in response to any increases in commodity prices or other market conditions;
uncertainties and liabilities inherent to conventional mineral extraction and recovery and/or in situ recovery (“ISR”);
risks associated with our commercial production of RE Carbonate, separated REE oxides and potentially other REE and REE-related value-added products (collectively, “RE Products”) at the Mill or elsewhere, including risks: that we may not be able to produce RE Products that meet commercial specifications at commercial levels or at all, or at acceptable cost levels; of not being able to secure adequate supplies of uranium and REE-bearing ores in the future at satisfactory costs; of not being able to increase our sources of uranium and REE-bearing ores to meet future planned production goals; of not being able to sell our RE Products at acceptable prices; of not being able to successfully construct and operate potential other downstream REE activities, including metal-making and alloying; of legal and regulatory challenges and delays; and the risk of technological or market changes that could impact the REE industry or our competitive position;
risks associated with the uranium reserve program for the U.S. (the “U.S. Uranium Reserve Program”) being subject to appropriation by the U.S. Congress, and the expansion of the U.S. Uranium Reserve Program;
risks associated with current federal, state and local administrations and changes thereto, including a lack of support of mining, uranium mining, nuclear energy, REE recovery or other aspects of our business;
geological, technical and processing problems, including unanticipated metallurgical difficulties, less than expected recoveries, ground control problems, process upsets and equipment malfunctions;
risks associated with the depletion of existing Mineral Resources through extraction without comparable replacements;
risks associated with identifying/obtaining adequate quantities of uranium-bearing materials not derived from conventional material (“Alternate Feed Materials”) and other feed sources required to operate our Mill;
risks associated with labor costs, labor disturbances and unavailability of skilled labor;
risks associated with availability and/or fluctuations in the costs of raw materials and consumables used in our production;
risks and costs associated with environmental compliance and permitting, including those created by changes in environmental legislation and regulation, changes in regulatory attitudes and approaches, and delays in obtaining permits and licenses that could impact expected mineral extraction and recovery levels and costs;
risks associated with increased regulatory requirements applicable to our operations in response to pressure from special interest groups or otherwise;
risks associated with our dependence on third parties in the provision of transportation and other critical services;
risks associated with our ability to obtain, extend or renew land tenure, including mineral leases and surface use agreements, and to negotiate access rights on certain properties, on favorable terms or at all;
risks associated with potential information security incidents, including cybersecurity breaches;
risks that we may compromise or lose our proprietary technology or intellectual property in certain circumstances, which could result in a loss in our competitive position and/or the value of our intangible assets;
risks associated with our ongoing ability to successfully develop, attract and retain qualified management, Board members and other key personnel critical to the success of our business, given limited significant experience in our industries;
competition for, among other things, capital, mineral properties and skilled personnel;
the adequacy of, and costs of retaining, our insurance coverage;
uncertainty as to reclamation and decommissioning liabilities;
the ability of our bonding companies to require increases in the collateral required to secure reclamation obligations;
the potential for, and outcome of, litigation and other legal proceedings, including potential injunctions pending resolution;
our ability to meet our obligations to our creditors and to access credit facilities on favorable terms;
risks associated with our relationships with our business and joint venture partners, including associated geopolitical risks;
failure to obtain industry partner, government, and other third-party consents and approvals, when required;
failure to complete and integrate proposed acquisitions, and/or to incorrectly assess the value of or risks associated with completed acquisitions, including our acquisition of mineral concessions at the Bahia Project, our acquisition of Base and its Toliara and Kwale Projects, our acquisition of a joint venture interest in the Donald Project, and any future acquisitions;
risks associated with the Toliara Project, including: risks associated with negotiating suitable fiscal terms for the Toliara Project with the Madagascar government on a timely basis or at all; risks associated with adding monazite to the Toliara Project’s mining permit on a timely basis, or at all; risks associated with the Madagascar government lifting the current suspension on the Toliara Project on a timely basis or at all; risks associated with the ability of the Company to maintain suitable fiscal terms with the Madagascar government over time; country risks, including the risk of government instability and expropriation risks; risks of challenges by special interest groups and other parties; and risks associated with reclamation of the Kwale Project;
5


human rights-related risks associated with the conduct of business in foreign countries, including risks associated with potential occurrences of forced labor, child labor and sex trafficking, that the Company may not be able to adequately identify and address;
risks associated with a Brazilian federal or state government enacting or engaging a conservation unit or environmental protection area or implementing a management plan in connection therewith that could impact planned production at or restrict the Company’s ability to or prevent the Company from mining significant portions of the Company’s Bahia Project;
risks associated with fluctuations in price levels for HMS concentrate (“HMC”) and its components, including the prices for ilmenite, rutile, titanium and zircon, which could impact planned production levels or the feasibility of production of HMC and monazite from our Bahia Project, Kwale Project, Toliara Project, the Donald Project and any other HMS project the Company may acquire or participate in, which could impact monazite supply for our RE Carbonate, separated REE oxide and any other REE value-added product production;
risks posed by fluctuations in share price levels, exchange rates and interest rates, and general economic conditions;
risks inherent in our and industry analysts’ forecasts/predictions of future uranium, vanadium, copper (if and when produced) HMC and REE price levels, including prices for RE Carbonates, separated REE oxides, and REE metals/metal alloys;
market prices of uranium, vanadium, REEs, HMC and (if relevant) copper, which are cyclical with substantial price fluctuations;
risks associated with future uranium sales, if any, being required to be made at spot prices, unless we are able to continue to enter into new long-term contracts at satisfactory prices in the future;
risks associated with our vanadium sales, if any, generally being required to be made at spot prices;
risks associated with our RE Carbonate sales and REE oxide and other REE product sales, if any, being tied to REE spot prices;
risks associated with our HMC and its component sales, if any, being tied to ilmenite, rutile, leucoxene and zircon spot prices as well as derived-product titanium and zirconium spot prices;
failure to obtain suitable uranium sales terms at satisfactory prices in the future, including spot and term sale contracts;
failure to obtain suitable vanadium sales terms at satisfactory prices in the future;
failure to obtain suitable copper (if and when produced), HMC and its components or REE sales terms at satisfactory prices in the future;
risks that we may not be able to fulfill all our sales commitments out of inventories or production and may be required to fulfill deliveries through spot purchases at a loss or through other negotiable means that are unfavorable to the Company;
risks associated with any expectation that we will successfully help in the cleanup of historic abandoned uranium mines;
risks associated with asset impairment as a result of market conditions;
risks associated with lack of access to markets and the ability to access capital;
risks associated with our ability to raise debt financing as may be required or desirable for planned expansion of our operations or for the development of projects with third parties in which we have a joint venture or other interest;
risks associated with public and/or political resistance to nuclear energy or uranium extraction and recovery;
risks associated with inaccurate or nonobjective media coverage of our activities and the impact such coverage may have on the public, the market for our securities, government relations, commercial relations, permitting activities and legal challenges, as well as the costs to us of responding to such coverage;
risks associated with potential impacts of public perceptions on our commercial relations;
uranium industry competition, international trade restrictions and the impacts they have on world commodity prices of foreign state-subsidized production, and wars or other conflicts influencing international demand and commercial relations;
risks associated with foreign government actions, policies and laws and foreign state-subsidized enterprises with respect to REE production and sales, which could impact REE prices, access to global and domestic markets for the supply of REE-bearing ores, and our sale of RE Carbonate, separated REE oxides or REE products and services globally and domestically;
risks associated with our involvement in industry petitions for trade remedies and the extension of the Russian Suspension Agreement, including costs of pursuing such remedies and the potential for negative responses/repercussions from various interest groups, uranium consumers and participants in other phases of the nuclear fuel cycle domestically and abroad;
risks associated with governmental or regulatory agency actions, policies, laws, regulations and interpretations with respect to nuclear energy or uranium extraction and recovery, and to HMS, REE and other mineral extraction and recovery activities;
risks related to potentially higher than expected costs related to any of our projects or facilities;
risks related to our ability to potentially recover copper from our Pinyon Plain Project, should we decide to pursue it;
risks related to stock price, volume volatility and market events and our ability to maintain listings in various stock indices;
risks related to our ability to maintain our listings on the NYSE American and the Toronto Stock Exchange (“TSX”);
risks related to dilution of currently outstanding shares from additional share issuances and/or depletion of assets, etc.;
risks related to our securities, including securities regulations, and our lack of dividends;
risks related to our issuance of additional freely tradeable common shares of the Company (“Common Shares”) under our At-the-Market program (“ATM”) or otherwise to provide adequate liquidity in depressed commodity market situations;
6


risks related to acquisition and integration issues, or related to defects in title to our mineral properties;
risks related to our method of accounting for equity investments in other companies potentially resulting in material changes to our financial results that are not fully within our control;
risks related to conducting business operations in foreign countries including heightened risks of expropriation of assets, business interruption, increased taxation, import/export controls, or unilateral modification of concessions and contracts;
risks related to any material weaknesses that may be identified in our internal controls over financial reporting. If we are unable to implement/maintain effective internal controls over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports, negatively affecting the market price of our common stock;
risks of amendment to mining laws, including the imposition of any royalties on minerals extracted from federal lands, the designation of national monuments, mineral withdrawals or similar actions, which could adversely impact our affected properties or our ability to operate our affected properties;
risks related to proposed or completed land exchanges made between federal and state agencies that may impact our unpatented mining claims and other rights, including: undesirable changes to our mineral tenure on exchanged lands; and/or the application of production royalties not previously owed on the claims;
risks related to our potential recovery of radioisotopes at the Mill for use in our TAT initiatives, including a risk of technological or market changes that could impact the industry or our competitive position, and any expectation that: such potential recovery will be feasible or that the radioisotopes will be able to be sold on a commercial basis; all required licenses, permits and regulatory approvals will be obtained on a timely basis or at all; and the cancer treatment therapeutics will receive the required approvals and will be commercially successful; and
risks that we will not fully acquire our planned joint venture interest in the Donald Project, or that the Bahia Project, Toliara Project and Donald Project will not reach a positive final investment decision and will not proceed as planned and be successful.
Such statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to, the following assumptions: that there is no material deterioration in general business and economic conditions; that there is no unanticipated fluctuation in interest rates and foreign exchange rates; that the supply and demand for, deliveries of, and the level and volatility of prices of uranium, vanadium, HMC, REEs and our other primary metals, radioisotopes and minerals develop as expected; that uranium, vanadium, HMC and REE prices required to reach, sustain or increase expected or forecasted production levels are realized as expected; that our HMC production, RE Carbonate production, planned production of separated REE oxides or any other proposed REE activities, our proposed radioisotope program, or other potential production activities will be technically or commercially successful; that we receive regulatory and governmental approvals for our development projects and other operations on a timely basis; that we are able to operate our mineral properties and processing facilities as expected; that we are able to implement new process technologies and operations as expected; that existing licenses and permits are renewed as required; that we are able to obtain financing for our development projects on reasonable terms; that we are able to procure mining equipment and operating supplies in sufficient quantities and on a timely basis; that engineering and construction timetables and capital costs for our development and expansion projects and restarting projects on standby are not incorrectly estimated or affected by unforeseen circumstances; that costs of closure of various operations are accurately estimated; that there are no unanticipated changes in collateral requirements for surety bonds; that there are no unanticipated changes to market competition; that our Mineral Reserve and Mineral Resource estimates are within reasonable bounds of accuracy (including with respect to size, grade and recoverability) and that the geological, operational and price assumptions on which these are based are reasonable; that environmental and other administrative and legal proceedings or disputes are satisfactorily resolved; that there are no significant changes to regulatory programs and requirements or interpretations that would materially increase regulatory compliance costs, bonding costs or licensing/permitting requirements; that there are no significant amendments to mining laws, including the imposition of any royalties on minerals extracted from federal lands; that there are no designations of national monuments, mineral withdrawals, land exchanges or similar actions, which could adversely impact any of our material properties or our ability to operate any of our material properties; that there are no conservation units or environmental protection areas or management plans that could impact planned production at or restrict the Company’s ability to or prevent the Company from mining significant portions of the Company’s Bahia Project or its other projects; that the Company is able to receive all required approvals, fiscal terms and permits from foreign governments; that there is no instability in foreign countries that would be expected to materially impact any of the Company’s existing or potential projects; and that we maintain ongoing relations with our employees and with our business and joint venture partners.
This list is not exhaustive of the factors that may affect our forward-looking statements. Some of the important risks and uncertainties that could affect forward-looking statements are described further under the section heading: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Quarterly Report. Although we have attempted to identify important factors that could cause actual results to differ materially from those described in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Except as required by applicable law, we disclaim any
7


obligation to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events. Statements relating to “Mineral Reserves” or “Mineral Resources” are deemed to be forward-looking statements, as they involve the implied assessment, based on certain estimates and assumptions, that the Mineral Reserves and Mineral Resources described may be profitably extracted in the future.
Market, Industry and Other Data
This Quarterly Report contains estimates, projections and other information concerning our industry, our business and the markets for our products. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from our own internal estimates and research, as well as from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry and general publications, government data and similar sources.
We qualify all forward-looking statements contained in this Quarterly Report by the foregoing cautionary statements.

8


CAUTIONARY NOTE TO INVESTORS CONCERNING
DISCLOSURE OF MINERAL RESOURCES AND RESERVES
We are a U.S. domestic issuer for United States Securities and Exchange Commission (“SEC”) reporting purposes, a majority of our outstanding voting securities are held by U.S. residents, we are required to report our financial results in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and our primary trading market is the NYSE American. However, because we are incorporated in Ontario, Canada and also listed on the TSX, this Quarterly Report also contains or incorporates by reference certain disclosure that satisfies the additional requirements of Canadian securities laws that differ from the requirements of U.S. securities laws.
All mineral estimates constituting mining operations that are material to our business or financial condition included in this Quarterly Report, and in the documents incorporated by reference herein, have been prepared in accordance with both 17 CFR Subparts 220.1300 and 229.601(b)(96) (collectively, “S-K 1300”), the SEC’s mining disclosure framework effective as of 2021, and Canadian National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”), a rule developed by the Canadian Securities Administrators (the “CSA”) that establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects. Furthermore, all mineral estimates constituting mining operations that are material to our business or financial condition included in this Quarterly Report are supported by pre-feasibility studies and/or initial assessments prepared in accordance with both the requirements of S-K 1300 and NI 43-101. S-K 1300 and NI 43-101 both provide for the disclosure of: (i) “Inferred Mineral Resources,” which investors should understand have the lowest level of geological confidence of all mineral resources and thus may not be considered when assessing the economic viability of a mining project and may not be converted to a Mineral Reserve; (ii) “Indicated Mineral Resources,” which investors should understand have a lower level of confidence than that of a “Measured Mineral Resource” and thus may be converted only to a “Probable Mineral Reserve”; and (iii) “Measured Mineral Resources,” which investors should understand have sufficient geological certainty to be converted to a “Proven Mineral Reserve” or to a “Probable Mineral Reserve.” Investors are cautioned not to assume that all or any part of Measured or Indicated Mineral Resources will ever be converted into Mineral Reserves as defined by S-K 1300 or NI 43-101. Investors are cautioned not to assume that all or any part of an Inferred Mineral Resource exists or is economically or legally mineable, or that an Inferred Mineral Resource will ever be upgraded to a higher category.
For purposes of S-K 1300 and NI 43-101, as of September 30, 2024, the Company is classified as a production stage issuer because it is engaged in the material extraction of mineral reserves on at least one material property. In late 2023, the Company commenced uranium production at three of its material properties, namely the Pinyon Plain Project and the La Sal and Pandora mines (each of the La Sal and Pandora mines constitutes a portion of the La Sal Project). The Pinyon Plain Project includes a Mineral Reserve and is considered by the Company to have reached viable commercial production as of April 1, 2024.
All mineral disclosures reported in this Quarterly Report have been prepared in accordance with the definitions of both S-K 1300 and NI 43-101.
9


PART I
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED).

ENERGY FUELS INC.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(unaudited) (Expressed in thousands of U.S. dollars, except per share amounts)
Three Months Ended September 30,Nine Months Ended
September 30,
2024202320242023
Revenues
Uranium concentrates$4,000 $10,473 $37,904 $33,278 
Vanadium concentrates   871 
RE Carbonate
 288  2,559 
Alternate Feed Materials, processing and other47 226 288 755 
Total revenues 4,047 10,987 38,192 37,463 
Costs applicable to revenues
Costs applicable to uranium concentrates1,847 5,266 16,580 15,318 
Costs applicable to vanadium concentrates   551 
Costs applicable to RE Carbonate 282  2,312 
Total costs applicable to revenues1,847 5,548 16,580 18,181 
Other operating costs and expenses
Exploration, development and processing3,619 2,516 8,911 9,432 
Standby1,645 2,281 4,641 6,175 
Accretion of asset retirement obligations327 282 916 902 
Selling, general and administration7,060 7,304 21,333 20,784 
Transactions and integration related costs1,462  4,747  
Total operating loss(11,913)(6,944)(18,936)(18,011)
Other income (loss)
Gain on sale of assets (Note 6)8  10 119,257 
Other income (loss) (Note 13)(174)17,413 4,066 18,603 
Total other income (loss)(166)17,413 4,076 137,860 
Net income (loss) and comprehensive income (loss)(12,079)10,469 (14,860)119,849 
Basic net income (loss) per common share (Note 10)$(0.07)$0.07 $(0.09)$0.76 
Diluted net income (loss) per common share (Note 10)$(0.07)$0.07 $(0.09)$0.75 
Net income (loss) and comprehensive income (loss) attributable to:
Owners of the Company$(12,060)$10,563 $(14,839)$119,968 
Non-controlling interests(19)(94)(21)(119)
Net income (loss) and comprehensive income (loss)$(12,079)$10,469 $(14,860)$119,849 

See accompanying notes to the condensed consolidated financial statements.
10


ENERGY FUELS INC.
Condensed Consolidated Balance Sheets
(unaudited) (Expressed in thousands of U.S. dollars, except share amounts)
September 30, 2024December 31, 2023
ASSETS
Current assets
Cash and cash equivalents$47,455 $57,445 
Marketable securities (Notes 4 and 15)101,154 133,044 
Trade and other receivables, net of allowance for credit losses of $223 and $223, as of September 30, 2024 and December 31, 2023, respectively
4,914 816 
Inventories (Note 5)35,910 38,868 
Prepaid expenses and other current assets4,490 2,522 
Total current assets193,923 232,695 
Mineral properties, net (Note 6)124,856 119,581 
Property, plant and equipment, net (Note 6)43,548 26,123 
Inventories (Note 5) 1,852 
Operating lease right of use asset1,079 1,219 
Investments (Note 7)12,130 1,356 
Intellectual property (Note 3)4,821  
Other long-term receivables 763 1,534 
Restricted cash (Note 8)19,284 17,579 
Total assets$400,404 $401,939 
LIABILITIES & EQUITY
Current liabilities
Accounts payable and accrued liabilities (Note 13)$8,213 $10,161 
Contingent consideration (Note 3)1,727  
Deferred revenue600  
Operating lease liability228 199 
Total current liabilities10,768 10,360 
Operating lease liability946 1,120 
Asset retirement obligations (Note 8)12,003 10,922 
Deferred revenue 332 
Total liabilities23,717 22,734 
Equity
Share capital
Common shares, without par value, unlimited shares authorized; shares issued and outstanding 164,678,756 and 162,659,155 as of September 30, 2024 and December 31, 2023, respectively
745,792 733,450 
Accumulated deficit(371,097)(356,258)
Accumulated other comprehensive loss(1,946)(1,946)
Total shareholders' equity372,749 375,246 
Non-controlling interests3,938 3,959 
Total equity376,687 379,205 
Total liabilities and equity$400,404 $401,939 
Commitments and contingencies (Note 14)

See accompanying notes to the condensed consolidated financial statements.
11


ENERGY FUELS INC.
Condensed Consolidated Statements of Changes in Equity
(unaudited) (Expressed in thousands of U.S. dollars, except share amounts)
 Common StockAccumulated Earnings (Deficit)Accumulated
Other
Comprehensive
Income (Loss)
Total
Shareholders'
Equity
Non-Controlling
Interests
Total Equity
 SharesAmount
Balance as of December 31, 2023162,659,155 $733,450 $(356,258)$(1,946)$375,246 $3,959 $379,205 
Net income (loss)— — 3,639 — 3,639 (1)3,638 
Shares issued for cash by at-the-market offering619,910 4,898 — — 4,898 — 4,898 
Share issuance cost— (110)— — (110)— (110)
Share-based compensation— 1,345 — — 1,345 — 1,345 
Shares issued for exercise of stock appreciation rights89,794 — — — — — — 
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights— (552)— — (552)— (552)
Shares issued for exercise of stock options29,116 103 — — 103 — 103 
Shares issued for the vesting of restricted stock units253,922 — — — — — — 
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units— (837)— — (837)— (837)
Balance as of March 31, 2024163,651,897 $738,297 $(352,619)$(1,946)$383,732 $3,958 $387,690 
Net loss— — (6,418)— (6,418)(1)(6,419)
Share-based compensation— 1,412 — — 1,412 — 1,412 
Shares issued for exercise of stock options9,214 53 — — 53 — 53 
Balance as of June 30, 2024163,661,111 $739,762 $(359,037)$(1,946)$378,779 $3,957 $382,736 
Net loss— — (12,060)— (12,060)(19)(12,079)
Share-based compensation— 1,027 — — 1,027 — 1,027 
Shares issued for exercise of stock options9,474 3 — — 3 — 3 
Shares issued for acquisition of intangible assets321,197 1,500 — — 1,500 — 1,500 
Shares issued for joint venture interests686,974 3,500 — — 3,500 — 3,500 
Balance as of September 30, 2024164,678,756 $745,792 $(371,097)$(1,946)$372,749 $3,938 $376,687 
12


Common StockDeficitAccumulated
Other
Comprehensive
Income (Loss)
Total
Shareholders'
Equity
Non-Controlling
Interests
Total Equity
SharesAmount
Balance as of December 31, 2022157,682,531 $698,493 $(456,120)$(1,946)$240,427 $3,982 $244,409 
Net income (loss)— — 114,265 — 114,265 (1)114,264 
Share-based compensation— 1,186 — — 1,186 — 1,186 
Shares issued for exercise of stock options34,219 72 — — 72 — 72 
Shares issued for the vesting of restricted stock units312,662 — — — — — — 
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units— (918)— — (918)— (918)
Balance as of March 31, 2023158,029,412 $698,833 $(341,855)$(1,946)$355,032 $3,981 $359,013 
Net loss— — (4,861)— (4,861)(24)(4,885)
Share-based compensation— 1,554 — — 1,554 — 1,554 
Shares issued for exercise of stock options45,126 312 — — 312 — 312 
Shares issued for exercise of stock appreciation rights164,258 — — — — — — 
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights— (848)— — (848)— (848)
Balance as of June 30, 2023158,238,796 $699,851 $(346,716)$(1,946)$351,189 $3,957 $355,146 
Net income (loss)— — 10,563 — 10,563 (94)10,469 
Share-based compensation— 1,293 — — 1,293 — 1,293 
Shares issued for exercise of stock options100,522 247 — — 247 — 247 
Shares issued for consulting services70,336 126 — — 126 — 126 
Shares issued for exercise of stock appreciation rights5,544 — — — — — — 
Shares issued for cash by at-the-market offering2,048,172 16,416 — — 16,416 — 16,416 
Share issuance cost— (369)— — (369)— (369)
Balance as of September 30, 2023160,463,370 $717,564 $(336,153)$(1,946)$379,465 $3,863 $383,328 

See accompanying notes to the condensed consolidated financial statements.
13


ENERGY FUELS INC.
Condensed Consolidated Statements of Cash Flows
(unaudited) (Expressed in thousands of U.S. dollars)

Nine Months Ended September 30,
20242023
OPERATING ACTIVITIES  
Net income (loss)$(14,860)$119,849 
Adjustments to reconcile net income (loss) to net cash used in operating activities:  
Depletion, depreciation and amortization1,999 2,024 
Share-based compensation3,784 4,033 
Accretion of asset retirement obligations916 902 
Unrealized foreign exchange (gain) loss331 (85)
Unrealized gain on investments (6,701)
Unrealized gain on convertible note (6,972)
Realized gain on marketable securities(1,704) 
Gain on sale of assets(10)(119,257)
Other, net(30)(682)
Changes in current assets and liabilities:  
Marketable securities1,346 (875)
Inventories6,782 10,807 
Trade and other receivables(3,384)(10,570)
Prepaid expenses and other current assets(1,948)(1,526)
Accounts payable and accrued liabilities(1,210)(1,929)
Net cash used in operating activities(7,988)(10,982)
INVESTING ACTIVITIES  
Additions to property, plant and equipment(20,684)(8,908)
Additions to mineral properties(6,220)(26,892)
Purchase of intangible assets(1,639) 
Purchases of marketable securities(184,284)(98,896)
Maturities of marketable securities216,533 41,931 
Purchase of investments(7,306) 
Proceeds from sale of assets10 56,873 
Proceeds from convertible note redemption 20,000 
Net cash used in investing activities(3,590)(15,892)
FINANCING ACTIVITIES  
Issuance of common shares for cash, net of issuance costs4,788 16,047 
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units(837)(918)
Cash received from exercise of stock options159 757 
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights(552)(848)
Net cash provided by financing activities3,558 15,038 
Effect of exchange rate fluctuations on cash held in foreign currencies(265)33 
Plus: release of restricted cash related to sale of assets 3,590 
Net change in cash, cash equivalents and restricted cash(8,285)(8,213)
Cash, cash equivalents and restricted cash, beginning of period75,024 80,269 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD$66,739 $72,056 

14


Nine Months Ended September 30,
20242023
Supplemental disclosure of cash flow information:
Cash paid during the period for interest$141 $13 
Increase (decrease) in accounts payable and accrued liabilities for property, plant and equipment and mineral properties$(464)$697 
Non-cash investing and financing transactions:
Shares issued for joint venture interests$3,500 $ 
Shares issued for acquisition of intangible assets$1,500 $ 
Contingent consideration for acquisition of intangible assets$1,690 $ 
Acquisition of convertible note$ $59,259 

See accompanying notes to the condensed consolidated financial statements.
15


ENERGY FUELS INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited) (Tabular amounts expressed in thousands of U.S. dollars, except share and per share amounts)
1.    THE COMPANY AND DESCRIPTION OF BUSINESS
Energy Fuels Inc. was incorporated under the laws of the Province of Alberta and was continued under the Business Corporations Act (Ontario).
Energy Fuels Inc. and its subsidiary companies (collectively the Company” or “Energy Fuels”) are together engaged in conventional and in situ recovery (“ISR”) uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties, along with the exploration, permitting and evaluation of uranium properties in the United States (the “U.S.”). As a part of these activities, the Company also acquires, explores, evaluates and, if warranted, permits uranium properties. The Company’s final uranium product, uranium oxide concentrate (“U3O8” or “uranium concentrate”), also known as “yellowcake,” is sold to customers for further processing into fuel for nuclear reactors. The Company also produces vanadium pentoxide (“V2O5”) as a co-product of uranium at the White Mesa Mill (the “White Mesa Mill” or the “Mill”), from certain of its Colorado Plateau properties and at times from solutions in its Mill tailings impoundment system, each as market conditions warrant. The Mill has produced rare earth elements (“REE”) carbonate (“RE Carbonate”) from various uranium- and REE-bearing materials acquired from third parties since 2021 and completed modifications and enhancements to its existing infrastructure for the production of separated REE products, producing separated neodymium/praseodymium (“NdPr”) in 2024.
The Company owns the Bahia Project in Brazil, which is an exploration/permitting stage property for the potential production of heavy mineral sands (“HMS”) that would be sold into the commercial HMS market while the associated monazite would be used as a feedstock ore for production of REEs and uranium at the Mill. On October 2, 2024, the Company acquired Base Resources Limited (“Base” or “Base Resources”) increasing its portfolio of other HMS/monazite/REE projects around the world (see Note 18 – Subsequent Events). Additionally, the Company is evaluating the potential to recover radioisotopes from its existing uranium process streams at the Mill for use in targeted alpha therapy (“TAT”) therapeutics for the treatment of cancer with RadTran LLC (“RadTran”) (See Note 3 – Transactions).
With its uranium, vanadium, REE, HMS and potential radioisotope production, the Mill is working to establish itself as a critical minerals hub in the U.S.

Energy Fuels produces both uranium and REEs. Uranium is the fuel for carbon-free, emission-free baseload nuclear power – one of the cleanest forms of energy in the world; REEs are used to manufacture permanent magnets for electric vehicles (“EVs”), wind turbines and other clean energy and modern technologies. Concurrently, the Company’s recycling program (which includes processing Alternate Feed Materials, recycling tailings solutions and performing other activities for the recovery of uranium, vanadium and potentially other metals and radionuclides) works to reduce the levels of new production and natural disturbances needed to meet global energy demand by recycling feed sources that would have otherwise been lost to direct disposal and extracting additional valuable minerals from them. Through its uranium and REE production and long-standing recycling program, Energy Fuels works to help address global climate change by producing materials that ultimately reduce reliance on carbon dioxide (“CO2”) emitters, such as fossil fuels, while also ensuring that materials already extracted but only partially utilized are instead used to the fullest extent practicable so as to limit the global mining footprint and reduce the number of constituents ultimately disposed of. Additionally, certain radioisotopes, which the Company is evaluating for recovery from its uranium processing streams, have the potential to provide the isotopes needed for emerging TAT cancer-fighting therapeutics.

As of September 30, 2024, the Company is a “production stage issuer” as defined by S-K 1300, as it is engaged in the material extraction of mineral reserves on at least one material property.
Mining Activities
The Company’s mining activities consist of the Mill, multiple conventional mining projects and an ISR mining project (complete with an ISR recovery facility on standby). The conventional mining projects are located on the Colorado Plateau, including the Pinyon Plain, Whirlwind, La Sal, Bullfrog, Arizona Strip and Roca Honda Projects, all of which are in the vicinity of the Mill, as well as the Sheep Mountain Project located in Wyoming and the Bahia Project (defined in Note 6 – Property, Plant and Equipment and Mineral Properties) located in Brazil. The Company’s Nichols Ranch Project (including the Jane Dough and Hank Satellite deposits) is an ISR project located in Wyoming.
As of September 30, 2024, the Company continued ore production at its Pinyon Plain, La Sal and Pandora Projects, as well as exploration drilling and analysis at its Nichols Ranch and Bahia Projects. Other conventional mining projects in the vicinity of
16


the Mill, as well as the Sheep Mountain Project, are on standby and are being evaluated for continued mining and other activities and/or are in the process of being permitted. The Mill continues to receive third-party uranium-bearing mineralized materials from mining and other industry activities for its own processing and recycling, while also expanding its REE initiatives and pursuing its TAT cancer-fighting therapeutics initiatives. On October 2, 2024, the Company acquired the Kwale HMS Project in Kenya and the Toliara HMS Project in Madagascar as part of its acquisition of Base Resources on October 2, 2024. See Note 18 – Subsequent Events.
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
These unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) applicable to interim financial information and should be read in conjunction with the consolidated financial statements and notes thereto and the summary of significant accounting policies included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on February 23, 2024, as amended June 28, 2024.
These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information, and, accordingly, do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements are presented in thousands of U.S. dollars, except for share and per share amounts. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included are adequate to make the information presented not misleading.
In management’s opinion, these unaudited condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring items, which are necessary for the fair presentation of the Company’s financial position, results of operations and cash flows on a basis consistent with that of the Company’s audited consolidated financial statements for the year ended December 31, 2023. However, the results of operations for the interim periods may not be indicative of results to be expected for the full fiscal year.
Principles of Consolidation
These unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated. The Company reports operating and financial results in a single segment based on the consolidated information used by the chief operating decision maker (“CODM”), who is the Company's Chief Executive Officer, in evaluating the financial performance of our business and allocating resources. This single segment reflects the Company's core business: the production of uranium and critical minerals. As the Company has one reportable segment, net income, total assets and working capital are equal to consolidated results. The CODM primarily uses operating expenses to manage operations.
Recently Adopted Accounting Standard
In November 2023, the FASB issued Accounting Standard Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires annual and interim disclosures about significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss as well as the amount and composition of other segment items. The Company adopted this standard prospectively on January 1, 2024, which did not have a material impact on the Company's unaudited condensed consolidated financial statements.
3.    TRANSACTIONS
Joint Venture with Astron on the Donald Project
On June 3, 2024, the Company executed binding agreements (collectively, the “JV Agreements”) with Astron Corporation Limited (“Astron”) for the creation of a joint venture (the “Donald Project JV”) to jointly develop and operate the Donald Rare Earth and Mineral Sands Project in Australia (the “Donald Project”). The Donald Project is a well-known HMS and rare earth deposit that the Company believes could provide it with another near-term, low-cost, and large-scale source of monazite sand that would be transported to the Mill for the recovery of separated REE products along with the contained uranium. The Donald Project has most licenses and permits in place (or at an advanced stage of completion). The JV Agreement provides Energy Fuels the right to invest up to AUS$183 million (approximately $127 million at September 30, 2024 exchange rates) to
17


earn up to a 49% interest in the Donald Project JV, of which approximately $10.6 million is expected to be invested in 2024 in preparation of a final investment decision (“FID”), and, if a positive FID is made, the remainder would be invested to develop the project and to earn into the full 49% interest in the Donald Project JV. In addition, the Company would issue Energy Fuels common shares (“Common Shares”) to Astron having a value of up to $17.5 million, of which $3.5 million of Common Shares were issued September 24, 2024 upon the satisfaction of certain conditions precedent (the “Completion Issuance”) and the remainder would be issued upon a positive FID. On September 25, 2024, the Donald Project JV was established and the Company earned an initial 3.21% interest in the Donald Project in exchange for the Completion Issuance and for funds invested in the Donald Project to that date. Astron, through its subsidiary Dickson & Johnson Pty Ltd, holds the remaining 96.79% interest.
The Company evaluated whether the Donald Project JV is a variable interest entity (“VIE”). Variable interests can be contractual, ownership or other pecuniary interests in an entity that change with changes in the fair value of the VIE’s assets. Based on its qualitative and quantitative contractual rights under the JV Agreements, Energy Fuels has a variable interest in the Donald Project JV. Additionally, the Company has determined that it does not have a controlling financial interest in the Donald Project JV because it does not have: (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and (ii) the obligation to absorb losses that could potentially be significant to the VIE or the right to receive benefits that could potentially be significant to the VIE as its ownership is less than 10% of the Donald Project JV. As of June 3, 2024, the Company had elected to account for the Donald Project JV as an investment without a readily determinable fair value at cost less impairment, and this investment is included in Investments on its unaudited Condensed Consolidated Balance Sheet. Upon Completion Issuance, the Company elected to account for the Donald Project JV as an equity method investment because the Company earned an initial 3.21% interest in the Donald Project and it exercises significant influence, but not control, over the entity. This investment is included in Investments on the Company's unaudited Condensed Consolidated Balance Sheet. The Company’s maximum exposure to loss on the Donald Project JV was $9.31 million as of September 30, 2024. Changes in the design or nature of the activities of the Donald Project JV, or the Company’s involvement with the Donald Project JV, may require the Company to reconsider its conclusions on the entity’s status as a VIE and/or whether the Company is not the primary beneficiary.
Acquisition of RadTran
On August 16, 2024, the Company acquired RadTran, a private company specializing in the separation of critical radioisotopes, to further the Company’s plans for development and production of medical isotopes used in cancer treatments. RadTran’s expertise includes separation of radium-226 (“Ra-226”) and radium-228 (“Ra-228”) from uranium and thorium process streams. This acquisition is expected to significantly enhance Energy Fuels’ planned capabilities to address the global shortage of these essential isotopes used in emerging TATs for cancer treatment.
Since July 2021, Energy Fuels and RadTran have been working under a Strategic Alliance Agreement to evaluate the feasibility of recovering Ra-226 and Ra-228 from existing uranium process streams at the Mill. Recovered Ra-226 and Ra-228 would be made available to the pharmaceutical industry and others to enable the production of actinium-225 (“Ac-225”), lead-212 (“Pb-212”) and potentially other leading medically attractive TAT isotopes. These isotopes are critical components in the development of targeted alpha therapies, which offer promising new treatments for various cancers. The global shortage of Ra-226 and Ra-228 currently presents itself as a significant barrier to the advancement and commercialization of these therapies. Energy Fuels received regulatory approval and licensing in 2023 for the concentration of research and development (“R&D”) quantities of Ra-226 at the Mill and is currently completing engineering on its R&D pilot facility for Ra-226 production.
Under the Acquisition, the purchase price paid by Energy Fuels to the owners of RadTran consisted of (all dollar amounts in US$): (i) on closing, $1.50 million in cash, $1.50 million in Common Shares and the grant of a 2% royalty on future revenues from the sale of produced radium, as well as certain other contractual commitments; and up to an additional $14.00 million total in cash and Common Shares based on the satisfaction of a number of performance-based milestones, including (i) $1.00 million in cash and $1.00 million in Common Shares upon achieving initial production; (ii) $1.00 million in cash and $1.00 million in Common Shares upon securing suitable offtake agreements to justify commercial production; and (iii) $10.00 million in cash upon reaching commercial production. As of September 30, 2024, the Company believes it is probable it will achieve the milestone related to achieving initial production.
18


In accordance with Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), the Company has accounted for the acquisition of RadTran as an asset acquisition as substantially all of the fair value of the assets acquired was concentrated in a group of similar identifiable assets. The purchase consideration includes cash paid at closing, common shares issued at closing, the fair value contingent consideration related to achieving initial production (see Note 15 – Fair Value), plus transaction costs, which was allocated to the acquired intellectual property. The contingent consideration is classified as a liability at its estimated fair value at each reporting period with subsequent revaluations recognized as an adjustment to the Intellectual property and Contingent consideration on the unaudited condensed combined Balance Sheet with a cumulative amortization adjustment. The total purchase consideration as of August 16, 2024 was $4.83 million calculated as follows:
Cash$1,500 
Issuance of Common Shares1,500 
Fair value of contingent consideration1,690 
Direct transaction costs139 
Total purchase consideration$4,829 
Intellectual property is amortized on a straight-line basis over a weighted average life of 13.5 years.
The following is a summary of intellectual property, net:
Intellectual property, as of August 16, 2024 $4,829 
Increase in fair value of contingent consideration37 
Amortization(45)
Intellectual property, as of September 30, 2024$4,821 
4.    MARKETABLE SECURITIES
The Company has elected the fair value option for its marketable debt securities and records these instruments on the Condensed Consolidated Balance Sheet at their fair value including interest income. Changes in fair value and interest income are recorded in Other income in the Condensed Consolidated Statements of Operations and Comprehensive Income. The fair value option was elected for these marketable debt securities, as the Company may sell them prior to their stated maturities after consideration of the Company’s risk versus reward objectives, as well as its liquidity requirements. The stated contractual maturity dates of marketable debt securities held as of September 30, 2024 and December 31, 2023 are due in one to two years. Marketable equity securities are measured at fair value as of each reporting date, and realized and unrealized gains (losses) and interest income are recorded in Other income in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
The following table summarizes our marketable securities by significant investment categories:
 Cost BasisGross Unrealized LossesGross Unrealized GainsFair Value
September 30, 2024
Marketable debt securities(1)
$76,247 $ $1,086 $77,333 
Marketable equity securities28,159 (4,338) 23,821 
Total marketable securities $104,406 $(4,338)$1,086 $101,154 
December 31, 2023
Marketable debt securities(1)
$106,791 $ $675 $107,466 
Marketable equity securities28,159 (2,581) 25,578 
Total marketable securities$134,950 $(2,581)$675 $133,044 
(1)     Marketable debt securities are comprised primarily of U.S. Treasury Bills and Government Agency Bonds.

19


5.    INVENTORIES
Inventories consisted of the following items:
 September 30, 2024December 31, 2023
Concentrates and work-in-progress$15,095 $35,807 
Inventory of ore in stockpiles15,895 3,072 
Raw materials and consumables4,920 1,841 
Total inventories$35,910 $40,720 

6.    PROPERTY, PLANT AND EQUIPMENT AND MINERAL PROPERTIES
Property, Plant and Equipment
The following is a summary of property, plant and equipment, net:

Estimated
Useful LivesSeptember 30, 2024December 31, 2023
LandN/A$642 $642 
Plant facilities
12 - 15 years
50,451 29,750 
Mining equipment
5 - 10 years
21,471 13,019 
Light trucks and utility vehicles5 years3,905 3,256 
Office furniture and equipment
4 - 7 years
1,909 1,754 
Construction-in-progress(1)
N/A4,203 13,627 
Total property, plant and equipment$82,581 $62,048 
Less: accumulated depreciation(39,033)(35,925)
Property, plant and equipment, net$43,548 $26,123 
(1)    Costs incurred for commissioning activities for the Companys Phase 1 REE separation circuit at the Mill are capitalized. The Company will offset these costs upon sale of separated neodymium-praseodymium (NdPr) that is produced during commissioning of the Phase 1 REE separation circuit.

The Company recognized depreciation expense of $0.66 million and $0.69 million for the three months ended September 30, 2024 and 2023, respectively, and $1.95 million and $2.02 million for the nine months ended September 30, 2024, and 2023, respectively. Depreciation expense is included in Exploration, development and processing as well as Standby in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
For the three months ended September 30, 2024 and 2023, the Company capitalized $0.46 million and $0.09 million of depreciation expense to inventory related to the Mill and production activities on the Condensed Consolidated Balance Sheets, respectively. For the nine months ended September 30, 2024 and 2023, the Company capitalized $0.94 million and $0.24 million, respectively, of depreciation expense to inventory related to the Mill on the Condensed Consolidated Balance Sheets.
For the three months ended September 30, 2023, the Company capitalized $0.06 million of depreciation expense to mineral properties on the Condensed Consolidated Balance Sheet. No depreciation expense was capitalized to mineral properties for the three months ended September 30, 2024. For the nine months ended September 30, 2024 and 2023, the Company capitalized $0.23 million and $0.13 million, respectively, of depreciation expense to mineral properties on the Condensed Consolidated Balance Sheet.
20


Mineral Properties
The following is a summary of mineral properties:
 September 30, 2024December 31, 2023
Sheep Mountain$34,183 $34,183 
Bahia Project32,613 29,130 
Nichols Ranch ISR Project25,974 25,974 
Roca Honda22,095 22,095 
Pinyon Plain9,338 6,512 
Other1,687 1,687 
Total mineral properties$125,890 $119,581 
Less: accumulated depletion$(1,034)$ 
Mineral properties, net$124,856 $119,581 
Capitalized costs to mineral properties are depleted using the units-of-production method (“UOP”) over the estimated life of the ore body based on estimated recoverable material to be produced from proven and probable reserves.
The calculation of the UOP rate of depletion could be materially impacted to the extent that actual production in the future is different from current forecasts of production based on proven and probable reserves. This would generally occur to the extent that there were significant changes in any of the factors or assumptions used in determining reserves. These changes could include: (i) an expansion of proven and probable reserves through exploration activity; (ii) differences between estimated and actual costs of production, due to differences in grade, recovery rates and foreign currency exchange rates; and (iii) differences between actual commodity prices and commodity price assumptions used in the estimation of reserves. If reserves decreased significantly, UOP depletion charged to operations would increase; conversely, if reserves increased significantly, UOP depletion charged to operations would decrease. Such changes in reserves could similarly impact the useful lives of assets depreciated on a straight-line basis, where those lives are limited to the life of the mine, which in turn is limited to the life of proven and probable reserves.
The expected useful lives used in depletion, depreciation and amortization calculations are determined based on the applicable facts and circumstances, as described above. As judgement is involved in the determination of useful lives, no assurance can be given that actual useful lives will not differ significantly from the useful lives assumed for the purpose of depletion, depreciation and amortization calculations.
Bahia Project
On February 10, 2023, the Company closed on two purchase agreements to acquire a total of 17 mineral concessions in the State of Bahia, Brazil totaling approximately 37,300 acres or 58.3 square miles (the “Bahia Project”). Under the terms of the purchase agreements, the Company entered into mineral rights transfer agreements with the sellers to acquire the 17 heavy mineral sands concessions.
The total purchase price under the purchase agreements was $27.50 million, which consisted of deposit payments of $5.90 million due upon reaching certain stipulated milestones and the remaining $21.60 million due at closing. Upon final payment on February 10, 2023, the transfer and assignment of the mineral rights was completed (the “Bahia Closing”). Additionally, the Company incurred direct deal costs related to such asset acquisitions of $1.63 million. The Bahia Closing followed the Brazilian Governments approval of the transfers to Energy Fuels wholly owned Brazilian subsidiary Energy Fuels Brazil Ltda.
Alta Mesa Transaction
On February 14, 2023, the Company closed on its sale to enCore Energy Corp. (“enCore”) of three wholly-owned subsidiaries that together held Alta Mesa for total consideration of $120 million (the “Alta Mesa Transaction”), paid as follows:
a.$60 million in cash, which included $6 million prior to closing and $54 million at closing; and
b.a $60 million secured convertible note (“Convertible Note”), payable in two years from the closing, bearing annual interest of eight percent (8%). The Convertible Note is convertible at Energy Fuels’ election into fully paid and non-assessable enCore common shares at a conversion price of $2.9103 per share, being a 20% premium to the 10-day
21


volume-weighted average price of enCore shares ending the day before the Closing (the “Conversion Option”). enCore is currently traded on the TSX-V and NYSE American. The Convertible Note is guaranteed by enCore and fully secured by Alta Mesa. Unless a block trade or similar distribution is executed by Energy Fuels to sell the enCore common shares received on conversion of the Convertible Note, Energy Fuels will be limited to selling a maximum of $10 million of enCore common shares per thirty (30)-day period.
The Company recognized a gain on sale of assets from the Alta Mesa Transaction of $116.50 million, which was calculated as the total fair value of the consideration received of $119.46 million consisting of $60 million in cash and the Convertible Note with a fair value of $59.46 million, less the net book value attributable to the Alta Mesa assets and liabilities after working capital adjustments of $3.40 million, net of transaction costs. Receipt of the Convertible Note represents a non-cash investing activity at its initial fair value. See Note 15 – Fair Value Accounting for more information on the fair value and current status of the Convertible Note.
As a post-closing condition of the Alta Mesa Transaction, enCore was required to replace the $3.59 million of reclamation bonds then in place for Alta Mesa. Upon replacement, the original bonds were released and the Company received back the underlying collateral. The Company reclassified $3.59 million cash as a release of collateral from those bonds from Property, plant and equipment and other assets held for sale, net to cash and cash equivalents on its Condensed Consolidated Balance Sheets.
In connection with the Alta Mesa Transaction, on May 3, 2023, the Company completed the sale of its Prompt Fission Neutron assets, including the underlying contracts, technology, licenses and intellectual property (collectively, the “PFN Assets”), to enCore in exchange for cash consideration received at closing of $3.10 million, which resulted in a gain of $2.75 million. At closing, the PFN Assets, which the Company had purchased in 2020 for cash consideration of $0.50 million, had a net book value of $0.35 million. The PFN Assets were used exclusively at the Alta Mesa ISR Project. Should the Company have the need for the use of a PFN tool in the future, the Company retained a 20-year usage right as a condition of this sale during which, subject to the availability of the PFN Assets, the Company has the right to purchase, lease and/or license at least one fully functional PFN tool and all related and/or required equipment, technology and licenses, as reasonably requested, on commercially reasonable terms and conditions no less favorable than those offered by enCore to third parties. As of September 30, 2024, the Company has not purchased, leased and/or licensed a PFN tool.

7.    INVESTMENTS
The Company’s investments include its equity method investment in the Donald Project JV and investments without readily determinable fair values. The following table is a reconciliation of the Company's investments:
September 30,
2024
December 31,
2023
Equity method investment$9,306 $ 
Investments without readily determinable fair values2,824 1,356 
Total investments$12,130 $1,356 
8.    ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH
Asset Retirement Obligations
The following table summarizes the Company’s asset retirement obligations:
Asset retirement obligations, December 31, 2023$10,922 
Revision of estimate165 
Accretion of liabilities916 
Asset retirement obligations, September 30, 2024$12,003 
The Company’s asset retirement obligations are subject to legal and regulatory requirements. Estimates of the costs of reclamation are reviewed periodically by the Company and the applicable regulatory authorities.
22


The upward revision of the estimate of $0.17 million for the nine months ended September 30, 2024 includes net changes in estimated costs of future reclamation activities. These revisions were recognized in Property, plant and equipment, net on the Consolidated Balance Sheet and will be depreciated over the useful life of the related asset.
Restricted Cash
The Company has cash, cash equivalents and fixed income securities as collateral for various bonds posted in favor of the applicable state regulatory agencies in Arizona, Colorado, New Mexico, Utah and Wyoming, and the U.S. Bureau of Land Management and U.S. Forest Service for estimated reclamation costs associated with the White Mesa Mill, Nichols Ranch and other mining properties. The restricted cash will be released when the Company has reclaimed a mineral property, sold a mineral property to a party having assumed the applicable bond requirements, or restructured the surety and collateral arrangements. See Note 14 – Commitments and Contingencies for more information.
The following table summarizes the Company’s restricted cash:
Restricted cash, December 31, 2023$17,579 
Additional collateral posted1,705 
Restricted cash, September 30, 2024$19,284 

9.    CAPITAL STOCK
Authorized Capital Stock
The Company is authorized to issue an unlimited number of Common Shares without par value, unlimited Preferred Shares issuable in series and unlimited Series A Preferred Shares. The Preferred Shares issuable in series will have the rights, privileges, restrictions and conditions assigned to the particular series upon the Board of Directors approving their issuance. The Series A Preferred Shares issuable are non-redeemable, non-callable, non-voting and have no right to dividends.
Issued Capital Stock
During the nine months ended September 30, 2024, the Company issued 0.62 million Common Shares under its at-the-market (the “ATM”) public offering program for net proceeds of $4.78 million after share issuance costs. No Common Shares were issued pursuant to the ATM during the three months ended September 30, 2024. During the three and nine months ended September 30, 2023, the Company issued 2.05 million Common Shares for net proceeds of $16.05 million pursuant to the ATM.

10.    BASIC AND DILUTED NET INCOME (LOSS) PER COMMON SHARE
Basic and diluted net income (loss) per Common Share
The calculation of basic net income (loss) per common share and diluted net income (loss) per common share after adjustment for the effects of all potential dilutive Common Shares is as follows:
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2024202320242023
Net income (loss) attributable to owners of the Company$(12,060)$10,563 $(14,839)$119,968 
Basic weighted average common shares outstanding163,882,537 158,616,883 163,650,699 158,235,301 
Dilutive impact of stock options and restricted stock units 1,167,832  1,217,624 
Diluted weighted average common shares outstanding163,882,537 159,784,715 163,650,699 159,452,925 
Basic net income (loss) per common share$(0.07)$0.07 $(0.09)$0.76 
Diluted net income (loss) per common share$(0.07)$0.07 $(0.09)$0.75 
For the three months ended September 30, 2024 and 2023, a weighted average of 1.71 million and 0.78 million, respectively, stock options and restricted stock units (“RSUs”) have been excluded from the calculation of diluted net income per common
23


share, as their effect would have been anti-dilutive. For the nine months ended September 30, 2024 and 2023 a weighted average of 1.61 million and 0.01 million respectively, stock options and RSUs have been excluded from the calculation of diluted net income per common share, as their effect would have been anti-dilutive. In addition, the Company excluded stock appreciation rights (“SARs”) of 1.02 million and 2.17 million, respectively, for the three months ended September 30, 2024 and 2023, as well as 1.02 million and 2.24 million, respectively, for the nine months ended September 30, 2024 and 2023 as they are contingently issuable based on specified market prices of the Company’s Common Shares, which were not achieved as of the end of each period.

11.    SHARE-BASED COMPENSATION
The Company maintains an equity incentive plan, known as the 2024 Amended and Restated Omnibus Equity Incentive Compensation Plan (as most recently amended and approved by the Company’s Board of Directors on May 24, 2024 and ratified by the Company’s shareholders at its Annual General and Special Meeting of Shareholders held on June 11, 2024) (the “Compensation Plan”), for directors, executives, eligible employees and consultants. Existing equity incentive awards include employee non-qualified stock options, RSUs and SARs. The Company issues new Common Shares to satisfy exercises and vesting under its equity incentive awards. Under the Compensation Plan, full value awards mean any award other than employee non-qualified stock options, SARs or similar awards, the value of which non-qualified stock options, SARs or similar award is based solely on an increase in the value of the Common shares over the grant price, option price or similar exercise price applicable to such award (“Full Value Awards”). The number of Common Shares reserved for issuance to participants under the Compensation Plan shall not exceed 10,000,000 (the “Total Share Authorization”). In addition to being subject to the Total Share Authorization limit, the aggregate number of Shares that may be issued under all Full Value Awards shall not exceed 7,500,000 (the “Full Value Share Authorization”). As of September 30, 2024, the total Common Shares authorized for future equity incentive plan awards was 7,230,770 Common Shares under the Total Share Authorization and 6,825,193 Common Shares under the Full Value Share Authorization.
The Company’s share-based compensation expense, by type of award, is as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
RSUs(1)
$636 $523 $2,218 $2,329 
SARs4 653 268 1,393 
Stock options387 117 1,298 311 
Total share-based compensation expense(2)
$1,027 $1,293 $3,784 $4,033 
(1)The fair value of the RSUs granted under the Compensation Plan for the three and nine months ended September 30, 2024 and 2023 was estimated at the date of grant using the stated market price on the NYSE American.
(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income.
As of September 30, 2024, there were $1.57 million, $0.03 million and $0.94 million of unrecognized compensation costs related to the unvested RSUs, SARs, and stock options, respectively. This expense is expected to be recognized over a weighted average period of 2.08 years, 0.28 years and 1.35 years, respectively.
Restricted Stock Units
The Company grants RSUs to directors, executives and eligible employees. Awards for executives and eligible employees are determined as a target percentage of base salary and generally vest over three years. Holders of unvested RSUs do not have voting rights on those RSUs. The RSUs are subject to forfeiture risk and other restrictions. Upon vesting, the employee is entitled to receive one Common Share of the Company for each RSU at no additional payment.
A summary of the Company’s unvested RSU activity is as follows:
24


 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2023641,839 $6.57 
Granted406,035 7.25 
Vested(373,067)6.20 
Forfeited  
Unvested, September 30, 2024674,807 $7.19 

The total fair value of RSUs that vested and were settled for equity was $2.72 million for the nine months ended September 30, 2024.
Stock Appreciation Rights
The Company has granted SARs to executives and eligible employees from time-to-time.
Most recently, on January 26, 2023, the Company’s Board of Directors issued SARs under the Compensation Plan, which are intended to provide additional long-term equity incentives for the Company’s senior management.
Each SAR granted vests on the satisfaction of certain performance goals, and once vested, entitles the holder to receive, upon a valid exercise, payment from the Company in cash or Common Shares (at the sole discretion of the Company) in an amount representing the difference between the fair market value (“FMV”) of the Company’s Common Shares on the date of exercise and grant price. Fair Market Value as used herein means the closing price of the Common Shares on the TSX or the NYSE American on the last trading day immediately prior to the date of exercise.
A summary of the Company’s SARs activity is as follows:
 Number of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 20231,839,528 $5.01 
Granted  
Exercised(250,036)2.92 
Forfeited(3,152)7.36 
Expired(569,595)2.94 
Outstanding, September 30, 20241,016,745 $6.67 2.55$
Exercisable, September 30, 2024 $ — $

A summary of the Company’s unvested SARs activity is as follows:

 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 20231,589,492 $2.89 
Granted  
Vested  
Expired(569,595)1.22 
Forfeited(3,152)3.45 
Unvested, September 30, 20241,016,745 $3.83 

25


Employee Stock Options
The Company, under the Compensation Plan, may grant stock options to directors, executives, employees and consultants to purchase Common Shares of the Company. The exercise price of the stock options is set as the higher of the Company’s closing share price on the NYSE American on the last trading day before the date of grant and the five-day VWAP on the NYSE American ending on the last trading day before the grant date. Stock options granted under the Compensation Plan generally vest over a period of two years or more and are generally exercisable over a period of five years from the grant date, such period not to exceed 10 years.
In January 2024, the Company granted stock options to its executives and certain other high-level employees stock options intended to incentivize senior management to achieve the Company’s strategic long-term goals over the specified terms of the grants, based on significant common share price growth objectives, and to reward management for achieving those growth objectives. The grant entitles the recipients to purchase one Common Share of the Company at an exercise price of $8.23 per share (the “Performance-Based Options”), being a 10% premium to the higher of (i) the VWAP of the Common Shares of the Company on the NYSE American for the five trading days ending on the last trading day prior to the date of the meeting when granted, and (ii) the closing price of the common shares of the Company on the NYSE American on the last trading day prior to the date of such meeting, which, as of January 24, 2024, was $7.48. The Performance-Based Options vest as to 50% on January 25, 2025 and as to the remaining 50% on January 25, 2026. The term of the Performance-Based Options is five years, ending on January 24, 2029.
The fair value of all stock options, including Performance Based Options, granted under the Compensation Plan for the nine months ended September 30, 2024 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
Risk-free interest rate4.67 %
Expected life3.09
Expected volatility(1)
68.82 %
Expected dividend yield %
Weighted average grant date fair value$3.44 
(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.
A summary of all of the Company’s stock option activity, including Performance Based Options, is as follows:
 Range of Exercise PricesNumber of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 2023
$1.76 - $8.60
523,468 $4.48 
 Granted
5.09 - 8.23
626,437 7.55 
 Exercised
1.76 - 6.47
(47,804)3.32 
 Forfeited
6.12 - 8.23
(30,012)7.35 
 Expired
2.92 - 7.36
(5,885)6.57 
Outstanding, September 30, 2024
$1.76 - $8.60
1,066,204 $6.25 3.15$751 
Exercisable, September 30, 2024
$1.76 - $8.41
399,742 $4.08 1.39$739 
26


A summary of the Company’s unvested stock option activity is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2023169,182 $4.11 
Granted626,437 3.44 
Vested(99,145)4.32 
Forfeited(30,012)3.67 
Unvested, September 30, 2024666,462 $3.47 


12.    INCOME TAXES
As of September 30, 2024, the Company maintained a full valuation allowance against its net deferred tax assets. The Company continually reviews the adequacy of the valuation allowance and intends to continue maintaining a full valuation allowance on its net deferred tax assets until there is sufficient evidence to support the reversal of all or a portion of the allowance. Should the Company’s assessment change in a future period, it may release all or a portion of the valuation allowance, which would result in a deferred tax benefit in the period of adjustment.
For the three and nine months ended September 30, 2024, the Company did not record income tax benefit on loss before tax of $12.08 million and $14.86 million, respectively. For the three and nine months ended September 30, 2023, the Company did not record income tax expense on income before tax of $10.47 million and $119.85 million, respectively. The effective tax rate was 0% for the three and nine months ended September 30, 2024 and 2023, which was a result of the full valuation allowance on net deferred tax assets.

13.    SUPPLEMENTAL FINANCIAL INFORMATION
The components of other income (loss) are as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Unrealized gain on investments$ $8,890 $ $6,701 
Unrealized gain (loss) on marketable securities(2,330)540 (1,346)875 
Realized gain on maturities of marketable securities843 374 1,704 588 
Unrealized gain on convertible note 7,223  6,972 
Realized gain on convertible note 181  181 
Foreign exchange gain (loss)22 (239)(331)80 
Interest income, net and other1,291 444 4,039 3,206 
Other income$(174)$17,413 $4,066 $18,603 
The components of trade and other receivables are as follows:
September 30, 2024December 31, 2023
Trade receivables$4,345 $406 
Notes receivable, net343 343 
Other226 67 
Total receivables$4,914 $816 
27


The components of accounts payable and accrued liabilities are as follows:
September 30, 2024December 31, 2023
Accounts payable$3,706 $1,006 
Accrued operating expenses1,022 4,391 
Accrued payroll liabilities3,078 4,162 
Accrued capital expenditures12 205 
Accrued taxes395 393 
Other accrued liabilities 4 
Accounts payable and accrued liabilities$8,213 $10,161 


14.    COMMITMENTS AND CONTINGENCIES
General Legal Matters
Other than routine litigation incidental to our business, or as described below, the Company is not currently a party to any material pending legal proceedings that management believes would be likely to have a material adverse effect on our financial position, results of operations or cash flows.
White Mesa Mill
In 2011, the Ute Mountain Ute Tribe filed an administrative appeal of the State of Utah Division of Air Quality’s (“UDAQ”) decision to approve a Modification to the Air Quality Approval Order at the Mill. Then, in 2013, the Ute Mountain Ute Tribe filed a Petition to Intervene and Request for Agency Action challenging the Corrective Action Plan approved by the State of Utah Department of Environmental Quality (“UDEQ”) relating to nitrate contamination in the shallow aquifer at the Mill. In August 2014, the Ute Mountain Ute Tribe filed an administrative appeal to the State of Utah Division of Radiation Control’s (“DRC”) Radioactive Materials License Amendment 7 approval regarding alternate feed material from Dawn Mining. The challenges remain open at this time and may involve the appointment of an administrative law judge (“ALJ”) to hear the matters. The Company does not consider these actions to have any merit. If the petitions are successful, the likely outcome would be a requirement to modify or replace the existing Air Quality Approval Order, Corrective Action Plan or license amendment, as applicable. At this time, the Company does not believe any such modifications or replacements would materially affect its financial position, results of operations or cash flows. However, the scope and costs of remediation under a revised or replaced Air Quality Approval Order, Corrective Action Plan and/or license amendment have not yet been determined and could be significant.
The UDEQ renewed in January 2018, then reissued with minor corrections in February 2018, the Mill’s radioactive materials license (the “Mill License”) for another ten years and the Groundwater Discharge Permit (the “GWDP”) for another five years, after which further applications for renewal of the Mill License and GWDP are required to be submitted. During the review period for each application for renewal, the Mill can continue to operate under its existing Mill License and GWDP until such time as the renewed Mill License or GWDP is issued. Most recently, on July 15, 2022, the routine GWDP renewal application was submitted to UDEQ, which remains under consideration at this time.
In 2018, the Grand Canyon Trust, Ute Mountain Ute Tribe and Uranium Watch (collectively, the “Mill Plaintiffs”) served Petitions for Review challenging UDEQ’s renewal of the Mill License and GWDP and Requests for Appointment of an ALJ, which they later agreed to suspend pursuant to a Stipulation and Agreement with UDEQ, effective June 4, 2018. The Company and the Mill Plaintiffs held multiple discussions over the course of 2018 and 2019 in an effort to settle the dispute outside of any judicial proceeding. In February 2019, the Mill Plaintiffs submitted to the Company their proposal for reaching a settlement agreement. The proposal remains under consideration by the Company. The Company does not consider these challenges to have any merit and, if a settlement cannot be reached, the Company intends to participate with UDEQ in defending against the challenges. If the challenges are successful, the likely outcome would be a requirement to modify the renewed Mill License and/or GWDP. At this time, the Company does not believe that any such modification would materially affect its financial position, results of operations or cash flows.
On August 26, 2021, the Ute Mountain Ute Tribe filed a Petition to Intervene and Petition for Review challenging the UDEQ’s approval of Amendment No. 10 to the Mill License, which expanded the list of Alternate Feed Materials that the Mill is authorized to accept and process for its source material content. Then, on November 18, 2021, the Tribe filed its Request for
28


Appointment of an ALJ, followed shortly thereafter by a stay on the request in accordance with a Stipulation and Agreement between the Tribe, UDEQ and Company. Thereafter, discussions between the Company and the Tribe commenced in an effort to resolve the dispute and other outstanding matters without formal adjudication. However, the Company does not consider this action to have any merit. If resolution is not achieved, the stay is lifted and the petition is successful before an ALJ, the likely outcome would be a requirement to modify or revoke the Mill License amendment. At this time, the Company does not believe any such modification or revocation would materially affect its financial position, results of operations or cash flows.
Mineral Property Commitments
The Company enters into commitments with federal and state agencies and private individuals to lease mineral rights. These leases are renewable annually, and, as reported in the Company’s Form 10-K for the year ended December 31, 2023, renewal costs for the remainder of 2024 are expected to total approximately $0.23 million.
Surety Bonds
The Company has indemnified third-party companies to provide surety bonds as collateral for the Company’s asset retirement obligations (“AROs”). The Company is obligated to replace this collateral in the event of a default and is obligated to repay any reclamation or closure costs due. As of September 30, 2024, the Company has $19.28 million posted as collateral against undiscounted AROs of $33.71 million. As of December 31, 2023, the Company has $17.58 million posted as collateral against undiscounted AROs of $33.38 million. The Company will be liable to pay any reclamation expense that exceeds the amount of the collateral posted against the surety bonds.
Commitments
The Company is contractually obligated under a Sales and Agency Agreement appointing an exclusive sales and marketing agent for all vanadium pentoxide produced by the Company.


15.    FAIR VALUE ACCOUNTING
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
Fair value accounting utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2 – Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).
The Company’s financial instruments as of September 30, 2024 and December 31, 2023 include cash, cash equivalents, restricted cash, accounts receivable, accounts payable and current accrued liabilities. These instruments are carried at cost, which approximates fair value due to the short-term maturities of the instruments. Allowances for doubtful accounts are recorded against the accounts receivable balance to estimate net realizable value.
The Company’s investments in marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 and Level 2 in the fair value hierarchy. Level 1 marketable equity securities use quoted prices for identical assets in active markets, while Level 2 marketable equity securities utilize inputs based upon quoted prices for similar instruments in active markets. The Company’s investments in marketable debt securities are valued using quoted prices of a pricing service and, as such, are classified within Level 2 of the fair value hierarchy. The Company’s investments accounted for at fair value consisting of common shares are valued using quoted market prices in active markets and, as such, are classified within Level 1 of the fair value hierarchy. The Company’s investments include certain investments accounted for at fair value consisting of
29


warrants are valued using the Black-Scholes option model based on observable inputs and, as such, are classified within Level 2 of the hierarchy.
The Convertible Note received as part of the Alta Mesa Transaction was valued as of February 14, 2023, upon closing, using a binomial lattice model. The fair value calculation used significant unobservable inputs within the Level 3 fair value hierarchy, including: (i) volatility 60%, and (ii) yield of 9.5%. Increases or decreases in the volatility and/or the selected yield can result in an increase or decrease in the fair value of the Convertible Note. Between February 14, 2023 and November 3, 2023, enCore early redeemed $40.00 million of the principal value of the Convertible Note. On November 9, 2023, the Company sold the remaining unpaid balance of $20 million owed under the secured Convertible Note for total consideration of $21.00 million plus $1.50 million in unpaid accrued interest, less a sales commission of $0.10 million paid to a third-party broker. As a result of enCore’s earlier pay-down and the $22.40 million received in connection with the sale of the Convertible Note, the Company received payment in full for the Alta Mesa Transaction, and no further consideration is owed in connection therewith.
The Company used the discounted cash flow approach, which is an income statement technique, to estimate the fair value of the its contingent consideration payment to RadTran using an indicated discount rate of 10.2%, as of the acquisition date, August 16, 2024 and 8.2% as of September 30, 2024, which is based on significant inputs not observable in the market, and thus represents a Level 3 measurement within the fair value hierarchy.
The following tables set forth the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis (at least annually) by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
Level 1Level 2Level 3Total
September 30, 2024
Assets
Cash equivalents(1)
$ $18,468 $ $18,468 
Marketable debt securities 77,333  77,333 
Marketable equity securities23,742 79